A welfare-focused guide to managing cats with chronic kidney disease (CKD), covering IRIS staging, quality of life assessment, and compassionate end-of-life planning.
Chronic kidney disease in cats requires careful welfare-centered management that balances intervention burden against quality of life. Early-stage CKD (IRIS Stage 1-2) often causes minimal clinical signs, and management should focus on dietary phosphorus restriction, hydration support, and monitoring. As disease progresses to Stage 3-4, cats may experience nausea, reduced appetite, lethargy, and hypertensive complications that require active management with phosphate binders, anti-emetics, antihypertensives, and subcutaneous fluids. Owners must be guided through honest quality of life assessment, recognizing that high intervention burden can itself reduce welfare. Regular veterinary assessment using validated quality of life scales helps owners make informed decisions. The goal is not simply extending life but maintaining good daily experiences — comfortable rest, appetite, social interaction, and freedom from pain. When quality of life deteriorates substantially despite management, timely euthanasia is the most compassionate choice.